Lead Exposure and Prevention Advisory Committee (LEPAC); Meeting, 17334 [2020-06367]
Download as PDF
<![CDATA[
17334
Federal Register / Vol. 85, No. 60 / Friday, March 27, 2020 / Notices
Evaluation Survey, in all
correspondence.
Beth Killoran,
Deputy Chief Information Officer.
[FR Doc. 2020–06440 Filed 3–26–20; 8:45 am]
BILLING CODE 6820–CX–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Lead Exposure and Prevention
Advisory Committee (LEPAC); Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This
meeting is open to the public by web
conference; however, advance
registration is needed by April 15, 2020,
to receive the information to join the
meeting. The registration link is https://
rossstrategic.zoom.us/webinar/register/
WN_I76JZ04RT5SVinnqu_tSYw. The
public comment period is scheduled on
April 29, 2020, from 1:45 p.m. until 2:00
p.m., EDT. Individuals wishing to make
a comment during the public comment
period, please email your name,
organization, and phone number by
April 15, 2020, to LEPAC@cdc.gov.
DATES: The meeting will be held on
April 29, 2020, from 9:00 a.m. to 4:30
p.m., EDT.
ADDRESSES: To receive web conference
access please register at https://
rossstrategic.zoom.us/webinar/register/
WN_I76JZ04RT5SVinnqu_tSYw by
April 15, 2020.
FOR FURTHER INFORMATION CONTACT: Ms.
Perri Ruckart, M.P.H., Designated
Federal Officer, National Center for
Environmental Health, CDC, 4770
Buford Highway, Atlanta, GA 30341,
770–488–3300; email address:
pruckart@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Lead Exposure and
Prevention Advisory Committee was
established under Section 2203 of
Public Law 114–322, the Water
Infrastructure Improvements for the
Nation Act; 42 U.S.C. 300j–27, Registry
for Lead Exposure and Advisory
Committee.
The Secretary, Department of Health
and Human Services (HHS) and by
delegation, the Director, CDC and
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:28 Mar 26, 2020
Jkt 250001
Administrator, NCEH/ATSDR, are
authorized under Section 2203 of Public
Law 114–322 (42 U.S.C. 300j–27) to
review research and Federal programs
and services related to lead poisoning
and to identify effective services and
best practices for addressing and
preventing lead exposure in
communities.
The LEPAC is charged with providing
advice and guidance to the Secretary,
HHS, and the Director, CDC and
Administrator, ATSDR, on the: (1)
Review of Federal programs and
services available to individual
communities exposed to lead; (2) review
current research on lead exposure to
identify additional research needs; (3)
review and identify best practices, or
the need for best practices regarding
lead screening and the prevention of
lead poisoning; (4) identify effective
services, including services relating to
healthcare, education, and nutrition for
individuals and communities affected
by lead exposure and lead poisoning,
including in consultation with, as
appropriate, the lead exposure registry
as established in Section 2203(b) of
Public Law 114–322; and (5) undertake
any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda
will include: Discussions on CDC’s role
in lead poisoning prevention, key
federal lead programs and the Federal
Lead Action Plan, methods and results
of a Community Guide environmental
scan and scoping review of lead
interventions, lessons learned from
review of CDC Childhood Lead
Poisoning Prevention Program (CLPPP)
cooperative agreement recipients, and
available services and best practices
regarding lead screening and the
prevention of lead poisoning. Agenda
items are subject to change as priorities
dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–06367 Filed 3–26–20; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Delegation of Authority
Notice is hereby given that the
Director, Centers for Disease Control
and Prevention (CDC), has delegated to
the Chief Operating Officer, Centers for
Disease Control and Prevention (CDC),
without the authority to redelegate, the
authority vested in the Secretary of HHS
by section 212(1) of the Department of
Defense and Labor, Health and Human
Services, and Education Appropriations
Act, 2019 and Continuing
Appropriations Act, 2019 (FY 19 HHS
Appropriations Act) Public Law 115–
245, division B, title II, or substantially
similar authorities vested in the
Secretary in the future by Congress, in
order to carry out international health
activities to respond to the current and
any future Ebola, polio, and coronavirus
outbreaks.
Section 212(1) of the FY19 HHS
Appropriations Act permits the
Secretary of HHS to exercise authority
equivalent to that available to the
Secretary of State under 22 U.S.C
2669(c) to award personal services
contracts for work performed in foreign
countries. The authority delegated
herein includes the authority to
determine the necessity of negotiating,
executing, and performing such
contracts without regard to statutory
provisions as related to the negotiation,
making, and performance of contracts
and performance of work in the United
States.
The authority under section 212(1) is
immediately revoked in the event that
any subsequent fiscal year HHS
appropriations act does not contain the
provision currently in section 212(1) or
substantially similar authority.
The Chief Operating Officer, CDC,
shall consult with the Secretary of State
and relevant Chief of Mission to ensure
that this authority is exercised in a
manner consistent with section 207 of
the Foreign Service Act of 1980 and
other applicable statutes administered
by the Department of State.
This delegation supersedes the
delegation of similar name, approved by
the Director, CDC, on September 26,
2019.
This delegation became effective on
March 17, 2020 and is valid through
fiscal year 2021. The Director, CDC,
affirms and ratifies any actions taken
that involve the exercise of the authority
E:\FR\FM\27MRN1.SGM
27MRN1
]]>Agencies
[Federal Register Volume 85, Number 60 (Friday, March 27, 2020)]
[Notices]
[Page 17334]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06367]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Lead Exposure and Prevention Advisory Committee (LEPAC); Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This meeting is open to the public by web
conference; however, advance registration is needed by April 15, 2020,
to receive the information to join the meeting. The registration link
is https://rossstrategic.zoom.us/webinar/register/WN_I76JZ04RT5SVinnqu_tSYw. The public comment period is scheduled on
April 29, 2020, from 1:45 p.m. until 2:00 p.m., EDT. Individuals
wishing to make a comment during the public comment period, please
email your name, organization, and phone number by April 15, 2020, to
[email protected].
DATES: The meeting will be held on April 29, 2020, from 9:00 a.m. to
4:30 p.m., EDT.
ADDRESSES: To receive web conference access please register at https://rossstrategic.zoom.us/webinar/register/WN_I76JZ04RT5SVinnqu_tSYw by
April 15, 2020.
FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, M.P.H., Designated
Federal Officer, National Center for Environmental Health, CDC, 4770
Buford Highway, Atlanta, GA 30341, 770-488-3300; email address:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Lead Exposure and Prevention Advisory Committee was
established under Section 2203 of Public Law 114-322, the Water
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-27,
Registry for Lead Exposure and Advisory Committee.
The Secretary, Department of Health and Human Services (HHS) and by
delegation, the Director, CDC and Administrator, NCEH/ATSDR, are
authorized under Section 2203 of Public Law 114-322 (42 U.S.C. 300j-27)
to review research and Federal programs and services related to lead
poisoning and to identify effective services and best practices for
addressing and preventing lead exposure in communities.
The LEPAC is charged with providing advice and guidance to the
Secretary, HHS, and the Director, CDC and Administrator, ATSDR, on the:
(1) Review of Federal programs and services available to individual
communities exposed to lead; (2) review current research on lead
exposure to identify additional research needs; (3) review and identify
best practices, or the need for best practices regarding lead screening
and the prevention of lead poisoning; (4) identify effective services,
including services relating to healthcare, education, and nutrition for
individuals and communities affected by lead exposure and lead
poisoning, including in consultation with, as appropriate, the lead
exposure registry as established in Section 2203(b) of Public Law 114-
322; and (5) undertake any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda will include: Discussions on
CDC's role in lead poisoning prevention, key federal lead programs and
the Federal Lead Action Plan, methods and results of a Community Guide
environmental scan and scoping review of lead interventions, lessons
learned from review of CDC Childhood Lead Poisoning Prevention Program
(CLPPP) cooperative agreement recipients, and available services and
best practices regarding lead screening and the prevention of lead
poisoning. Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-06367 Filed 3-26-20; 8:45 am]
BILLING CODE 4163-18-P
